Furthermore, IL-22 is reported to drive endogenous thymic regeneration 43, and TP5 alleviated DSS-induced thymic atrophy, thus thymus could supply more T cells to peripheral tissues to maintain immune homeostasis after TP5 treatment, forming a positive feedback loop. The gene discussed is TMPO; the disease is thymus atrophy.